A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer

被引：0
|
作者：
Kagawa, Y. [1 ]
Kato, T. [2 ]
Bando, H. [3 ]
Akagi, K. [4 ]
Denda, T. [5 ]
Nishina, T. [6 ]
Komatsu, Y. [7 ]
Oki, E. [8 ]
Kudo, T. [9 ]
Yamanaka, T. [10 ]
Yoshino, T. [11 ]
机构：
[1] Kansai Rosai Hosp, Dept Gastrointestinal Surg, Amagasaki, Hyogo, Japan
[2] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan
[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[4] Saitama Canc Ctr, Ina, Saitama, Japan
[5] Chiba Canc Ctr, Chiba, Japan
[6] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[7] Hokkaido Univ Hosp, Div Canc Ctr, Digest Internal Med, Sapporo, Hokkaido, Japan
[8] Kyushu Univ, Grad Sch Med Sci, Dept Surg, Higashi Ku, Fukuoka, Japan
[9] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[10] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
[11] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 005
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Study of circulating tumor DNA (ctDNA) of RAS-wild metastatic colorectal cancer (mCRC) as a tool for on-site mutation screening: A prospective study.
    Sawada, Takeshi
    Nakamura, Keishi
    Takahashi, Naoki
    Kubota, Eiji
    Sugiyama, Manabu
    Nakano, Shunsuke
    Ichijo, Toshimitsu
    Sakai, Rie
    Numai, Daisuke
    Nakanishi, Hiroyoshi
    Inagaki, Satoko
    Wakita, Shigenori
    Ota, Ryosuke
    Hasatani, Kenkei
    Tsuji, Kunihiro
    Doyama, Hisashi
    Izawa, Naoki
    Tsuyada, Akihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
    Osumi, Hiroki
    Shinozaki, Eiji
    Takeda, Yoshinori
    Wakatsuki, Takeru
    Ichimura, Takashi
    Saiura, Akio
    Yamaguchi, Kensei
    Takahashi, Shunji
    Noda, Tetsuo
    Zembutsu, Hitoshi
    CANCER MEDICINE, 2019, 8 (01): : 408 - 417
  • [33] Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients
    Galbiati, Silvia
    Damin, Francesco
    Brambilla, Dario
    Ferraro, Lucia
    Soriani, Nadia
    Ferretti, Anna M.
    Burgio, Valentina
    Ronzoni, Monica
    Vago, Riccardo
    Sola, Laura
    Chiari, Marcella
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 13
  • [34] Association of k-ras mutational status and clinical outcomes in patients with metastatic colorectal. cancer receiving panitumumab alone
    Freeman, Daniel J.
    Juan, Todd
    Reiner, Maureen
    Hecht, J. Randolph
    Meropol, Neal J.
    Berlin, Jordan
    Mitchell, Edith
    Sarosi, Ildiko
    Radinsky, Robert
    Amado, Rafael G.
    CLINICAL COLORECTAL CANCER, 2008, 7 (03) : 184 - 190
  • [35] Methylated circulating tumor DNA in plasma as a biomarker for treatment efficacy in metastatic colorectal cancer
    Raunkilde, L.
    Hansen, T. F.
    Andersen, R. F.
    Jensen, L. H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S713 - S713
  • [36] CLINICAL POTENTIAL OF CIRCULATING TUMOR CELLS IN COLORECTAL CANCER: A PROSPECTIVE STUDY
    Park, Eun Young
    Baek, Dong Hoon
    Kim, Gwang Ha
    Song, Geun Am
    Park, Do Youn
    Lee, Sung Hoon
    Lee, Bong Eun
    GASTROENTEROLOGY, 2019, 156 (06) : S367 - S368
  • [37] Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study
    Baek, Dong Hoon
    Kim, Gwang Ha
    Song, Geun Am
    Han, In Sub
    Park, Eun Young
    Kim, Hyun Sung
    Jo, Hong Jae
    Ko, Sang Hwa
    Park, Do Youn
    Cho, Yoon-Kyung
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10
  • [38] Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment
    Iguchi, Kenta
    Shiozawa, Manabu
    Uchiyama, Mamoru
    Asari, Masahiro
    Numata, Koji
    Rino, Yasushi
    Saito, Aya
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [39] Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.
    Takayama, Yuji
    Suzuki, Koichi
    Fukui, Taro
    Ichida, Kosuke
    Watanabe, Fumiaki
    Kakizawa, Nao
    Kikugawa, Rina
    Hasegawa, Fumi
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Konishi, Fumio
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Mutational landscape of circulating tumor DNA identifies distinct molecular features associated with therapeutic response in patients with metastatic colorectal cancer
    Shi, Min
    Yuan, Hong
    Ji, Jun
    Zhang, Shouwei
    Li, Qingyuan
    Chen, Yawei
    Gong, Xiaoli
    Zhu, Zhenggang
    Zhang, Jun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
12345